Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Ischemic Heart Disease

  Free Subscription


Articles published in Thromb Haemost

Retrieve available abstracts of 47 articles:
HTML format
Text format



Single Articles


    April 2017
  1. CHRISTERSSON C, Thulin A, Siegbahn A
    Microparticles during long-term follow-up after acute myocardial infarction. Association to atherosclerotic burden and risk of cardiovascular events.
    Thromb Haemost. 2017 Apr 20. doi: 10.1160/TH16-11-0837.
    PubMed     Text format     Abstract available


    March 2017
  2. CAMPO G, Vieceli Dalla Sega F, Pavasini R, Aquila G, et al
    Biological effects of ticagrelor over clopidogrel in patients with stable coronary artery disease and chronic obstructive pulmonary disease.
    Thromb Haemost. 2017 Mar 23. doi: 10.1160/TH16-12-0973.
    PubMed     Text format     Abstract available


  3. THOMAS MR, Angiolillo DJ, Bonaca MP, Ajjan RA, et al
    Consistent platelet inhibition with ticagrelor 60 mg twice-daily following myocardial infarction regardless of diabetes status.
    Thromb Haemost. 2017 Mar 16. doi: 10.1160/TH16-09-0703.
    PubMed     Text format     Abstract available


  4. TARANCON-DIEZ L, De Pablo-Bernal RS, Alvarez-Rios AI, Rosado-Sanchez I, et al
    CCR5+ CD8 T-cell levels and monocyte activation precede the onset of acute coronary syndrome in HIV-infected patients on antiretroviral therapy.
    Thromb Haemost. 2017 Mar 9. doi: 10.1160/TH16-11-0867.
    PubMed     Text format     Abstract available


    February 2017

  5. Erratum to Rutten et al. "Platelet density per monocyte predicts adverse events in patients after percutaneous coronary intervention" (Thromb Haemost 2016; 115: 353-360).
    Thromb Haemost. 2017;117:641.
    PubMed     Text format    


  6. URBANSKI K, Ludew D, Filip G, Filip M, et al
    CD14+CD16++ "nonclassical" monocytes are associated with endothelial dysfunction in patients with coronary artery disease.
    Thromb Haemost. 2017 Feb 23. doi: 10.1160/TH16-08-0614.
    PubMed     Text format     Abstract available


  7. ALLAN V, Honarbakhsh S, Casas JP, Wallace J, et al
    Are cardiovascular risk factors also associated with the incidence of atrial fibrillation? A systematic review and field synopsis of 23 factors in 32 population based cohorts of 20 million participants.
    Thromb Haemost. 2017 Feb 23. doi: 10.1160/TH16-11-0825.
    PubMed     Text format     Abstract available


  8. FREYNHOFER MK, Iliev L, Bruno V, Rohla M, et al
    Platelet turnover predicts outcome after coronary intervention.
    Thromb Haemost. 2017 Feb 23. doi: 10.1160/TH16-10-0785.
    PubMed     Text format     Abstract available


  9. NIEZGODA P, Sikora J, Baranska M, Sikora A, et al
    Crushed sublingual versus oral ticagrelor administration strategies in patients with unstable angina. A pharmacokinetic/pharmacodynamic study.
    Thromb Haemost. 2017 Feb 16. doi: 10.1160/TH16-08-0670.
    PubMed     Text format     Abstract available


  10. PARK Y, Tantry US, Koh JS, Ahn JH, et al
    Novel role of platelet reactivity in adverse left ventricular remodelling after ST-segment elevation myocardial infarction: The REMODELING Trial.
    Thromb Haemost. 2017 Feb 2. doi: 10.1160/TH16-10-0744.
    PubMed     Text format     Abstract available


  11. ASHER E, Frydman S, Katz M, Regev E, et al
    Chewing versus Swallowing Ticagrelor to Accelerate Platelet Inhibitionin Acute Coronary Syndrome - the CHEERS study. For The PLATIS (Platelets and Thrombosis in Sheba) Study Group.
    Thromb Haemost. 2017 Feb 2. doi: 10.1160/TH16-09-0728.
    PubMed     Text format     Abstract available


    December 2016
  12. ZAKAI NA, McClure LA, Judd SE, Kissela B, et al
    D-dimer and the Risk of Stroke and Coronary Heart Disease. The REasons for Geographic and Racial Differences in Stroke (REGARDS) Study.
    Thromb Haemost. 2016 Dec 22. doi: 10.1160/TH16-07-0519.
    PubMed     Text format     Abstract available


  13. GAO J, Ma X, Zhang Y, Guo M, et al
    The role of microRNAs in prethrombotic status associated with coronary artery disease.
    Thromb Haemost. 2016 Dec 22. doi: 10.1160/TH16-07-0503.
    PubMed     Text format     Abstract available


    November 2016
  14. SCHOOLING CM, Zhong Y
    Plasma levels of the anti-coagulation protein C and the risk of ischaemic heart disease. A Mendelian randomisation study.
    Thromb Haemost. 2016.
    PubMed     Text format     Abstract available


  15. KREUTZ RP, Schmeisser G, Maatman B, Schaffter A, et al
    Fibrin clot strength measured by thrombelastography and outcomes after percutaneous coronary intervention.
    Thromb Haemost. 2016.
    PubMed     Text format    


    October 2016
  16. POURDJABBAR A, Hibbert B, Chong AY, Le May MR, et al
    A randomised study for optimising crossover from ticagrelor to clopidogrel in patients with acute coronary syndrome. The CAPITAL OPTI-CROSS Study.
    Thromb Haemost. 2016;117.
    PubMed     Text format     Abstract available


  17. FLIERL U, Zauner F, Sieweke JT, Berliner C, et al
    Efficacy of prasugrel administration immediately after percutaneous coronary intervention in ST-elevation myocardial infarction.
    Thromb Haemost. 2016;117.
    PubMed     Text format     Abstract available


    September 2016
  18. SIBBING D, Aradi D, Jacobshagen C, Gross L, et al
    A randomised trial on platelet function-guided de-escalation of antiplatelet treatment in ACS patients undergoing PCI. Rationale and design of the Testing Responsiveness to Platelet Inhibition on chronic Antiplatelet Treatment for Acute Coronary Syndr
    Thromb Haemost. 2016;117.
    PubMed     Text format     Abstract available


  19. DARWICHE W, Bejan-Angoulvant T, Angoulvant D, Babuty D, et al
    Risk of myocardial infarction and death in patients with atrial fibrillation treated with dabigatran or vitamin K antagonists. Meta-analysis of observational analyses.
    Thromb Haemost. 2016;116.
    PubMed     Text format     Abstract available


    July 2016
  20. WEBER C, Shantsila E, Hristov M, Caligiuri G, et al
    Role and analysis of monocyte subsets in cardiovascular disease. Joint consensus document of the European Society of Cardiology (ESC) Working Groups "Atherosclerosis & Vascular Biology" and "Thrombosis".
    Thromb Haemost. 2016;116.
    PubMed     Text format     Abstract available


  21. ANTIOCHOS P, Marques-Vidal P, Virzi J, Pagano S, et al
    Association between anti-apolipoprotein A-1 antibodies and cardiovascular disease in the general population. Results from the CoLaus study.
    Thromb Haemost. 2016;116.
    PubMed     Text format     Abstract available


    May 2016
  22. SANTILLI F, Marchisio M, Lanuti P, Boccatonda A, et al
    Microparticles as new markers of cardiovascular risk in diabetes and beyond.
    Thromb Haemost. 2016;116.
    PubMed     Text format     Abstract available


    April 2016
  23. THOMAS MR, Morton AC, Hossain R, Chen B, et al
    Morphine delays the onset of action of prasugrel in patients with prior history of ST-elevation myocardial infarction.
    Thromb Haemost. 2016;116.
    PubMed     Text format     Abstract available


  24. EGHOLM G, Thim T, Olesen KK, Madsen M, et al
    Dual anti-platelet therapy after coronary drug-eluting stent implantation and surgery-associated major adverse events.
    Thromb Haemost. 2016;116.
    PubMed     Text format     Abstract available


  25. NAGATSUKA K, Miyata S, Kada A, Kawamura A, et al
    Cardiovascular events occur independently of high on-aspirin platelet reactivity and residual COX-1 activity in stable cardiovascular patients.
    Thromb Haemost. 2016;116.
    PubMed     Text format     Abstract available


  26. CHIVA-BLANCH G, Crespo J, Suades R, Arderiu G, et al
    CD142+/CD61+, CD146+ and CD45+ microparticles predict cardiovascular events in high risk patients following a Mediterranean diet supplemented with nuts.
    Thromb Haemost. 2016;116.
    PubMed     Text format     Abstract available


    March 2016
  27. DE CATERINA R, Husted S, Wallentin L, Andreotti F, et al
    Oral anticoagulants in coronary heart disease (Section IV). Position paper of the ESC Working Group on Thrombosis - Task Force on Anticoagulants in Heart Disease.
    Thromb Haemost. 2016;115.
    PubMed     Text format     Abstract available


  28. WHITE SJ, Newby AC, Johnson TW
    Endothelial erosion of plaques as a substrate for coronary thrombosis.
    Thromb Haemost. 2016;115:509-19.
    PubMed     Text format     Abstract available


  29. MORBIDUCCI U, Kok AM, Kwak BR, Stone PH, et al
    Atherosclerosis at arterial bifurcations: evidence for the role of haemodynamics and geometry.
    Thromb Haemost. 2016;115:484-92.
    PubMed     Text format     Abstract available


    February 2016
  30. EVANS PC, Gijsen FJ, Wentzel JJ, van der Heiden K, et al
    Biomechanics in vascular biology and cardiovascular disease.
    Thromb Haemost. 2016;115:465-466.
    PubMed     Text format    


    January 2016
  31. SIEGBAHN A, Oldgren J, Andersson U, Ezekowitz MD, et al
    D-dimer and factor VIIa in atrial fibrillation - prognostic values for cardiovascular events and effects of anticoagulation therapy. A RE-LY substudy.
    Thromb Haemost. 2016;115.
    PubMed     Text format     Abstract available


  32. FLIERL U, Rontgen P, Zauner F, Tongers J, et al
    Platelet inhibition with prasugrel in patients with acute myocardial infarction undergoing therapeutic hypothermia after cardiopulmonary resuscitation.
    Thromb Haemost. 2016;115.
    PubMed     Text format     Abstract available


  33. STEPPICH B, Hadamitzky M, Ibrahim T, Groha P, et al
    Stem cell mobilisation by granulocyte-colony stimulating factor in patients with acute myocardial infarction. Long-term results of the REVIVAL-2 trial.
    Thromb Haemost. 2016;115.
    PubMed     Text format     Abstract available


  34. KWON TJ, Tantry US, Park Y, Choi YM, et al
    Influence of platelet reactivity on BARC classification in East Asian patients undergoing percutaneous coronary intervention. Results of the ACCEL-BLEED study.
    Thromb Haemost. 2016;115.
    PubMed     Text format     Abstract available


  35. VIOLI F, Davi G, Proietti M, Pastori D, et al
    Ankle-Brachial Index and cardiovascular events in atrial fibrillation. The ARAPACIS Study.
    Thromb Haemost. 2016;115.
    PubMed     Text format     Abstract available


  36. KIM JS, Han DC, Jeong YH, Park DW, et al
    Antiplatelet effect of ticagrelor compared to tirofiban in non-ST-segment elevation ACS patients undergoing PCI. The result of the TE-CLOT trial.
    Thromb Haemost. 2016;115:213-21.
    PubMed     Text format     Abstract available


  37. POHL J, Hendgen-Cotta UB, Rammos C, Luedike P, et al
    Targeted intracellular accumulation of macrophage migration inhibitory factor in the reperfused heart mediates cardioprotection.
    Thromb Haemost. 2016;115:200-12.
    PubMed     Text format     Abstract available


  38. HERTLE E, Arts IC, van der Kallen CJ, Feskens EJ, et al
    The alternative complement pathway is longitudinally associated with adverse cardiovascular outcomes. The CODAM study.
    Thromb Haemost. 2016;115:446-57.
    PubMed     Text format     Abstract available


  39. ASHER E, Fefer P, Sabbag A, Herscovici R, et al
    Prior chronic clopidogrel therapy is associated with increased adverse events and early stent thrombosis.
    Thromb Haemost. 2016;115:433-8.
    PubMed     Text format     Abstract available


  40. VERGALLO R, Aguirre AD, Abtahian F, Minami Y, et al
    Recurrent myocardial infarctions and premature coronary atherosclerosis in a 23-year-old man with antiphospholipid syndrome.
    Thromb Haemost. 2016;115:237-9.
    PubMed     Text format    


  41. COLLET JP, Kerneis M, Hulot JS, O'Connor SA, et al
    Point-of-care genetic profiling and/or platelet function testing in acute coronary syndrome.
    Thromb Haemost. 2016;115:382-91.
    PubMed     Text format     Abstract available


  42. RUTTEN B, Roest M, McClellan EA, Sels JW, et al
    Platelet density per monocyte predicts adverse events in patients after percutaneous coronary intervention.
    Thromb Haemost. 2016;115:353-60.
    PubMed     Text format     Abstract available


    December 2015
  43. FRANCHI F, Rollini F, Cho JR, King R, et al
    Effects of dabigatran on the cellular and protein phase of coagulation in patients with coronary artery disease on dual antiplatelet therapy with aspirin and clopidogrel. Results a prospective, randomised, double-blind, placebo-controlled study.
    Thromb Haemost. 2015;115.
    PubMed     Text format     Abstract available


    March 2015
  44. FERNANDEZ-SANZ C, Ruiz-Meana M, Castellano J, Miro-Casas E, et al
    Altered FoF1 ATP synthase and susceptibility to mitochondrial permeability transition pore during ischaemia and reperfusion in aging cardiomyocytes.
    Thromb Haemost. 2015;113:441-51.
    PubMed     Text format     Abstract available


  45. SIMSEKYILMAZ S, Liehn EA, Militaru C, Vogt F, et al
    Progress in interventional cardiology: challenges for the future.
    Thromb Haemost. 2015;113:464-72.
    PubMed     Text format     Abstract available


  46. VON HUNDELSHAUSEN P, Oexle K, Bidzhekov K, Schmitt MM, et al
    Recurrent spontaneous coronary dissections in a patient with a de novo fibrillin-1 mutation without Marfan syndrome.
    Thromb Haemost. 2015;113:668-70.
    PubMed     Text format    


  47. SCHRECKENBERG R, Weber P, Cabrera-Fuentes HA, Steinert I, et al
    Mechanism and consequences of the shift in cardiac arginine metabolism following ischaemia and reperfusion in rats.
    Thromb Haemost. 2015;113:482-93.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: